[Federal Register Volume 76, Number 118 (Monday, June 20, 2011)]
[Notices]
[Pages 35913-35914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-15130]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0010]


Agency Information Collection Activities: Proposed Collection; 
Comments Requested: U.S. Official Order Forms for Schedule I and II 
Controlled Substances (Accountable Forms); Order Form Requisition; DEA 
Form 222, 222a, Controlled Substances Order System

ACTION: 30-Day notice of information collection under review.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register at Volume 76, Number 71, 
Page 20710, April 13, 2011, allowing for a 60-day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until July 20, 2011. This process is conducted in 
accordance with 5 CFR 1320.10.
    If you have comments, especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Cathy A. Gallagher, Acting Chief, Liaison 
and Policy Section, Office of Diversion Control, Drug Enforcement 
Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202) 
307-7297.
    Written comments concerning this information collection should be 
sent to the Office of Information and Regulatory Affairs, Office of 
Management and Budget, Attn: DOJ Desk Officer. The best way to ensure 
your comments are received is to e-mail them to [email protected] or fax them to (202) 395-7285. All comments 
should reference the eight-digit OMB number for the collection or the 
title of the collection. If you have questions concerning the 
collection, please contact Cathy A. Gallagher, Acting Chief, Liaison 
and Policy Section, Office of Diversion Control, Drug Enforcement 
Administration, 8701 Morrissette Drive, Springfield, VA 22152, (202) 
307-7297, or the DOJ Desk Officer at (202) 395-3176.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agencies estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.

Overview of Information Collection 1117-0010

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: U.S. Official Order Forms for 
Schedule I and II Controlled Substances (Accountable Forms); Order Form 
Requisition.
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection:
    Form number: DEA Forms 222 and 222a.
    Component: Office of Diversion Control, Drug Enforcement 
Administration, Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: Not-for-profit; State, local or Tribal government.
    Abstract: DEA-222 is used to transfer or purchase Schedule I and II 
controlled substances and data are needed to provide an audit of 
transfer and purchase. DEA-222a Requisition Form is used to obtain the 
DEA-222 Order Form. Persons may also digitally sign and transmit orders 
for controlled substances electronically, using a digital certificate. 
Orders for Schedule I and II controlled substances are archived and 
transmitted to DEA.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that 109,632

[[Page 35914]]

registrants participate in this information collection, taking an 
estimated 17.33 hours per registrant annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: It is estimated that there are 1,898,970 annual 
burden hours associated with this collection.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, Department of Justice, Two Constitution Square, 
145 N Street, NE., Suite 2E-808, Washington, DC 20530.

Jerri Murray,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2011-15130 Filed 6-17-11; 8:45 am]
BILLING CODE 4410-09-P